G. Martel, P. Dutar, J. Epelbaum, and C. Viollet, Somatostatinergic systems: an update on brain functions in normal and pathological aging, Front Endocrinol, vol.3, p.154, 2012.

G. Lepousez, Z. Csaba, V. Bernard, C. Loudes, C. Videau et al., Somatostatin interneurons delineate the inner part of the external plexiform layer in the mouse main olfactory bulb, J Comp Neurol, vol.518, pp.1976-94, 2010.

A. Kepecs and G. Fishell, Interneuron cell types are fit to function, Nature, vol.505, pp.318-344, 2014.

H. Taniguchi, M. He, P. Wu, S. Kim, R. Paik et al., A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex, Neuron, vol.71, issue.6, pp.995-1013, 2011.

T. Zeyda and U. Hochgeschwender, Null mutant mouse models of somatostatin and cortistatin, and their receptors, Mol Cell Endocrinol, vol.286, issue.1-2, pp.18-25, 2008.

G. Martel, A. Simon, S. Nocera, S. Kalainathan, L. Pidoux et al., Aging, but not tau pathology, impacts olfactory performances and somatostatin systems in THY-Tau22 mice (total), Neurobiol Aging, vol.36, pp.1013-1041, 2015.

D. Grouselle, R. Winsky-sommerer, J. P. David, A. Delacourte, P. Dournaud et al., Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele, Neurosci Lett, vol.255, pp.21-25, 1998.

R. Hassouna, P. Zizzari, C. Tomasetto, J. D. Veldhuis, O. Fiquet et al., An early reduction in GH peak amplitude in preproghrelin-deficient male mice has a minor impact on linear growth, Endocrinology, vol.155, pp.3561-71, 2014.

F. J. Steyn, L. Huang, S. T. Ngo, J. W. Leong, H. Y. Tan et al., Development of a method for the determination of pulsatile growth hormone secretion in mice, Endocrinology, vol.152, issue.8, pp.3165-71, 2011.

R. Hassouna, P. Zizzari, and V. Tolle, The ghrelin/obestatin balance in the physiological and pathological control of GH secretion, body composition and food intake, J Neuroendocrinol, issue.7, pp.793-804, 2010.

J. M. Adams, V. Otero-corchon, G. L. Hammond, J. D. Veldhuis, N. Qi et al., Somatostatin is essential for the sexual dimorphism of GH secretion, corticosteroid-binding globulin production, and corticosterone levels in mice, Endocrinology, vol.156, issue.3, pp.1052-65, 2015.

L. C. Lin and E. Sibille, Somatostatin, neuronal vulnerability and behavioral emotionality, Mol Psychiatry, vol.20, issue.3, pp.377-87, 2015.

M. J. Low, V. Otero-corchon, A. F. Parlow, J. L. Ramirez, U. Kumar et al., Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth, J Clin Invest, vol.107, issue.12, pp.1571-80, 2001.

J. A. Harris, K. E. Hirokawa, S. A. Sorensen, H. Gu, M. Mills et al., Anatomical characterization of Cre driver mice for neural circuit mapping and manipulation, Front Neural Circuits, vol.8, p.76, 2014.

D. K. Murphey, A. M. Herman, and B. R. Arenkiel, Dissecting inhibitory brain circuits with genetically-targeted technologies, Front Neural Circuits, vol.18, p.124, 2014.

A. M. Herman, L. Huang, D. K. Murphey, I. Garcia, and B. R. Arenkiel, Cell type-specific and time-dependent light exposure contribute to silencing in neurons expressing channelrhodopsin-2, Elife, vol.3, p.1481, 2014.

E. Harno, E. C. Cottrell, and A. White, Metabolic pitfalls of CNS Cre-based technology, Cell Metab, vol.18, issue.1, pp.21-29, 2013.

H. Hu, J. Z. Cavendish, and A. Agmon, Not all that glitters is gold: off-target recombination in the somatostatin-IRES-Cre mouse line labels a subset of fast-spiking interneurons, Front Neural Circuits, p.195, 2013.

M. Chahrour, S. Y. Jung, C. Shaw, X. Zhou, S. T. Wong et al., MeCP2, a key contributor to neurological disease, activates and represses transcription, Science, vol.320, pp.1224-1233, 2008.

M. Lovett-barron, P. Kaifosh, M. A. Kheirbek, N. Danielson, J. D. Zaremba et al., Dendritic inhibition in the hippocampus supports fear learning, Science, vol.343, pp.857-63, 2014.

L. Lin and E. Sibille, Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?, Front Pharmacol, vol.4, p.110, 2013.

C. Viollet, G. Lepousez, C. Loudes, C. Videau, A. Simon et al., Somatostatinergic systems in brain: networks and functions, Mol Cell Endocrinol, vol.286, pp.75-87, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00531952

J. Guilloux, G. Douillard-guilloux, R. Kota, X. Wang, A. M. Gardier et al., Molecular evidence for BDNF-and GABA-related dysfunctions in the amygdala of female subjects with major depression, Mol Psychiatry, vol.17, issue.11, pp.1130-1172, 2012.

L. C. Lin and E. Sibille, Transcriptome changes induced by chronic psychosocial/ environmental or neuroendocrine stressors reveal a selective cellular vulnerability of cortical somatostatin (SST) neurons, compared with pyramidal (PYR) neurons, Mol Psychiatry, vol.20, issue.3, p.285, 2015.